April 19, 2014 2:28 PM ET

Pharmaceuticals

Company Overview of Genyous Biomed International, Inc.

Executive Profile

Mark Pegram Ph.D,MD

Member of Breast Cancer Advisory Board, Exagen Diagnostics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Mark Pegram, Ph.D, MD, serves as Associate Professor of Medicine in the Division of Hematology and Oncology at School of Medicine, the University of California Los Angeles. Dr. Pegram serves as Director of Women's Cancer Program at the UCLA and Johnson Comprehensive Cancer Center. He serves as Member of Breast Cancer Advisory Board of exagen Diagnostics, Inc. He has been a Member of the Scientific Advisory Board at Sagres Discovery, Inc. since November 2003. Dr. ...

Corporate Headquarters

2830 Forest Grove Drive
Henderson, Nevada 89052

United States

Phone: 650-580-3872
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genyous Biomed International, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.